MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cognitive profile of Parkinson’s disease (PD) in the Framingham Heart Study (FHS)

A. Gurnani, J. Dookhy, Y. Liu, Y. Li, S. O'Shea, S. Frank, R. Au, J. Mez, T. Alvin Ang, L. Shih (Framingham, USA)

Meeting: 2024 International Congress

Abstract Number: 254

Keywords: Cognitive dysfunction, Dementia, Parkinson’s

Category: Parkinson's Disease: Cognitive functions

Objective: Characterize the cognitive profiles of individuals with PD within a population-based study

Background: Understanding the cognitive state of those with PD early in its course has consequences on functioning, caregiver burden, and mortality. Most epidemiologic studies of PD use brief neuropsychological batteries or cognitive screens that are insufficiently sensitive to detect cognitive changes. This study aims at describing cognitive performance among individuals with PD within a longitudinal, community-based, epidemiological study.

Method: The sample consisted of the FHS Original and Offspring cohorts. Surveillance for incident dementia has been conducted since 1976 including serial neuropsychological assessments (NP) since 1999. Participants (ppts) were deemed to have PD based on consensus adjudication by two movement disorders neurologists, based on the UK Parkinson’s Disease Brain Bank Diagnostic Criteria. Mild cognitive impairment (MCI) or dementia was diagnosed through consensus adjudication based on DSM IV and Petersen criteria. Descriptive statistics were derived from ppts NP exam closest to PD onset. Cases with exams greater than 5 years from PD onset were excluded.

Results: Ppts with PD (n=190) were white, non-Hispanic adults (M age, 77.78 ± 9.23), 62.5% male, and 80% with at least a high school degree. About half the ppts had at least one NP test within 5 years of PD diagnosis (n=96); 65% had their closest NP test before or in the same year as their PD diagnosis and mean timing between NP test and PD onset was 1.5 years. For the 47 cognitively normal (PD-CN) individuals deemed at the time of the NP test, age-, sex-, and education-adjusted z-scores were comparable to the non-PD group, with exception of significantly lower performance on symbol digit coding (z=-0.65, 95%CI [-1.24, -0.05]). The 49 ppts with PD that were cognitively impaired or demented at the time of their NP test had significantly worse performance than the PD-CN group on tasks of verbal learning (z=-0.84, 95%CI [-1.14, -0.55]) and verbal memory (z=-0.74, 95%CI [-1.03, -0.45]) and visual learning (z=-0.81, 95%CI [-1.14, -0.48]) and visual memory (z=-0.85, 95%CI [-1.09, -0.61]).

Conclusion: In this community-based study, individuals with PD who eventually developed cognitive impairment or dementia had observable differences in cognitive performance near the time of PD onset and across multiple cognitive domains.

Table 1

Table 1

Table 2

Table 2

Table 3 part 1

Table 3 part 1

Table 3 part 2

Table 3 part 2

To cite this abstract in AMA style:

A. Gurnani, J. Dookhy, Y. Liu, Y. Li, S. O'Shea, S. Frank, R. Au, J. Mez, T. Alvin Ang, L. Shih. Cognitive profile of Parkinson’s disease (PD) in the Framingham Heart Study (FHS) [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/cognitive-profile-of-parkinsons-disease-pd-in-the-framingham-heart-study-fhs/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cognitive-profile-of-parkinsons-disease-pd-in-the-framingham-heart-study-fhs/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley